WuXi Biologics (Cayman) (OTCMKTS:WXXWY) Sees Unusually-High Trading Volume – Still a Buy?

WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) saw unusually-strong trading volume on Wednesday . Approximately 130,387 shares were traded during trading, an increase of 82% from the previous session’s volume of 71,527 shares.The stock last traded at $13.7380 and had previously closed at $13.78.

Analyst Ratings Changes

Separately, Zacks Research upgraded WuXi Biologics (Cayman) to a “hold” rating in a report on Friday, August 28th. One equities research analyst has rated the stock with a Hold rating, According to MarketBeat.com, the company presently has a consensus rating of “Hold”.

WuXi Biologics (Cayman) Price Performance

The firm’s fifty day moving average is $11.60 and its 200-day moving average is $9.68.

About WuXi Biologics (Cayman)

WuXi Biologics (Cayman) is a global contract research, development and manufacturing organization (CRDMO) focused on biologic medicines. The company provides integrated services to pharmaceutical and biotechnology customers across the development cycle, from early-stage discovery and preclinical research through clinical development, regulatory support and commercial manufacturing.

Its capabilities include the development and production of monoclonal antibodies, recombinant proteins, vaccines, antibody-drug conjugates and other biologic modalities.